老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Cellectar Biosciences Inc.

4.70
-0.1000-2.08%
盘后：4.820.1236+2.63%19:14 EDT
成交量：11.83万
成交额：56.15万
市值：851.66万
市盈率：-0.20
高：4.86
开：4.62
低：4.62
收：4.80
数据加载中...
总览公司新闻公告
2020/06/11

重要事件披露

8-K - Current report
2020/06/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/05

重要事件披露

8-K - Current report
2020/06/03

重要事件披露

8-K - Current report
2020/06/01

SEC问询函

CORRESP [Cover] - Correspondence
2020/06/01

重要事件披露

8-K - Current report
2020/05/26

重要事件披露

8-K - Current report
2020/05/20

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/05/20

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/05/14

重要事件披露

8-K - Current report
2020/05/08

招股说明书

General form for registration of securities under the Securities Act of 1933
2020/05/07

季度报告

Quarterly report [Sections 13 or 15(d)]
2020/05/07

重要事件披露

Current report, items 2.02 and 9.01
2020/03/09

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/09

重要事件披露

Current report, items 2.02 and 9.01
2020/02/20

重要事件披露

Current report, items 7.01 and 9.01
2020/02/19

重要事件披露

Current report, items 7.01 and 9.01
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/11

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
更多